Novel IMB-ELISA assay for rapid diagnosis of human toxoplasmosis using SAG1 antigen

13Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

Nanotechnology is important for medical diagnosis. Various nanoparticles have presented tremendous potential for diagnosing disease markers, pre-cancerous cells, fragment of viruses, specific proteins, antibodies, and other disease indicators. In general, nanoparticles are smaller than 1,000 nm and produced from different materials in different shapes such as spheres, rods, wires, and tubes. Our study aimed to develop a novel antigen-capture immunoassay based on IgG polyclonal anti-body-coated magnetic microbead nanoparticles for the rapid detection of circulating surface antigen 1 of Toxoplasma gondii in human serum samples. Sandwich ELISA elicited a sensitivity of 92%, a specificity of 92.7%, a positive predictive value (PPV) of 92%, and a negative predictive value (NPV) of 92.7%. Immunomagnetic bead-ELISA showed sensitivity (98%), specificity (96.4%), PPV (96%), and NPV (98.1%) higher than that of sandwich ELISA. It is obvious that the use of magnetic microbead nanoparticles offers the potential advantage of improving the diagnostic testing of toxoplasmosis.

Cite

CITATION STYLE

APA

Hegazy, S., Farid, A., Rabae, I., & El-Amir, A. (2015). Novel IMB-ELISA assay for rapid diagnosis of human toxoplasmosis using SAG1 antigen. Japanese Journal of Infectious Diseases, 68(6), 474–480. https://doi.org/10.7883/yoken.JJID.2014.444

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free